Therefore, we analyzed the significance of first-line POD24 in advanced ER-high HER2-negative breast cancer patients, and our conclusion also verified that the prognosis of ER-positive HER2-negative breast cancer patients with first-line POD24 was worse and PR-negative patients were more likely to occur first-line POD24. This evidence concerns the gene PGR and breast carcinoma.